Massimo Falconi
Impact in
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Epidemiology top 0.02%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 537
- Pancreatic and Hepatic Oncology Research 471
- Lung Cancer Research Studies 85
- Epidemiology 304
- Neuroendocrine Tumor Research Advances 289
- Co-authors
- Claudio Bassi (127 shared papers)Paolo Pederzoli (72 shared papers)Stefano Crippa (225 shared papers)Stefano Partelli (239 shared papers)Roberto Salvia (90 shared papers)Aldo Scarpa (55 shared papers)P. Pederzoli (64 shared papers)Paola Capelli (37 shared papers)
- Journals
- Pancreatology (52 papers)Digestive and Liver Disease (46 papers)Annals of Surgery (45 papers)Annals of Surgical Oncology (36 papers)Surgery (32 papers)
- Partner nations
- ItalyUnited StatesCanada
In The Last Decade
Massimo Falconi
814 papers receiving 49.4k citations
Massimo Falconi's Hit Papers
Peers
Comparison fields: 5 of 162
- Oncology 32.7k
- Epidemiology 17.4k
- Neurology 6.0k
- Cancer Research 5.3k
- Surgery 11.4k
Countries citing papers authored by Massimo Falconi
This map shows the geographic impact of Massimo Falconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Falconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Falconi more than expected).
Fields of papers citing papers by Massimo Falconi
This network shows the impact of papers produced by Massimo Falconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Falconi. The network helps show where Massimo Falconi may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Falconi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 854 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After Hit paper breakdown → | 2016 | 3230 |
| 2 | Detection and localization of surgically resectable cancers with a multi-analyte blood test Hit paper breakdown → | 2018 | 2180 |
| 3 | A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer Hit paper breakdown → | 2004 | 2152 |
| 4 | Whole genomes redefine the mutational landscape of pancreatic cancer Hit paper breakdown → | 2015 | 2115 |
| 5 | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Hit paper breakdown → | 2012 | 1767 |
| 6 | International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas Hit paper breakdown → | 2005 | 1634 |
| 7 | TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Hit paper breakdown → | 2006 | 1268 |
| 8 | ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors Hit paper breakdown → | 2016 | 1018 |
| 9 | Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Hit paper breakdown → | 2001 | 862 |
| 10 | Whole-genome landscape of pancreatic neuroendocrine tumours Hit paper breakdown → | 2017 | 774 |
| 11 | 2006 | 684 | |
| 12 | 2004 | 616 | |
| 13 | Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids Hit paper breakdown → | 2015 | 519 |
| 14 | Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers Hit paper breakdown → | 2017 | 466 |
| 15 | Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway Hit paper breakdown → | 2009 | 455 |
| 16 | 2012 | 406 | |
| 17 | 2010 | 371 | |
| 18 | European experts consensus statement on cystic tumours of the pancreas Hit paper breakdown → | 2013 | 371 |
| 19 | 2012 | 367 | |
| 20 | 2015 | 360 |
About Massimo Falconi
Massimo Falconi is a scholar working on Oncology, Epidemiology, Surgery, Neurology and Cancer Research, having authored 854 papers that have together received 50.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (471 papers), Neuroendocrine Tumor Research Advances (289 papers), Pancreatitis Pathology and Treatment (139 papers), Lung Cancer Research Studies (85 papers), Neuroblastoma Research and Treatments (77 papers), Cancer Genomics and Diagnostics (53 papers), Gallbladder and Bile Duct Disorders (38 papers) and Renal cell carcinoma treatment (31 papers). The work is most often cited by research in Oncology (32.7k citations), Epidemiology (17.4k citations), Neurology (6.0k citations), Cancer Research (5.3k citations) and Surgery (11.4k citations). Massimo Falconi has collaborated with scholars based in Italy, United States and Canada. Frequent co-authors include Claudio Bassi, Paolo Pederzoli, Stefano Crippa, Stefano Partelli, Roberto Salvia, Aldo Scarpa, P. Pederzoli, Paola Capelli, Suresh T. Chari and Letizia Boninsegna. Their work appears in journals such as Pancreatology, Digestive and Liver Disease, Annals of Surgery, Annals of Surgical Oncology and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.